Project Engineering Director of BeiGene Biotech
Michael Lee’s experience in the area of biopharmaceutical / pharmaceutical manufacturing covers operations & new facility projects. Michael also serves at ISPE China for its technical committee & training committee.
Michael was the Plant Director of JHL Biotech before joining BeiGene. JHL was the first KUBio Project delivered to global biomanufacturing industry. With KUBio, this biopharmaceutical factory was built efficiently for scalable and cost-effective manufacturing. Sixty Two (62) prefabricated modules with FlexFactory Single-Use Equipment provide the technical solution.
These 62 modules are produced in a controlled environment for additional quality control. Each module’s design includes the specific materials needed for that room in the KUBio. Electrical, water, and ventilation equipment was installed in JHL’s modules, and factory acceptance testing was performed prior to transport. Process equipment was manufactured and tested before shipping. Simultaneously, JHL prepared the Wuhan site for arrival of the KUBio modules.
He was VP of project and manufacturing at Shanghai Biomabs, a leading monoclonal antibody development & manufacturing company in China.
He also held senior technical positions as Plant Director/Project Director at GSK, Roche, Merial and Boehringer Ingelheim.
He was involved in establishing Shanghai Roche facilities at Zhangjiang Hi-Tech Park in Shanghai China. His experience in leading the capital investment projects of establishing new biopharmaceutical facilities covers vaccines and monoclonal antibodies in China for sites at various locations such as Shanghai, Nanjing, Nanchang, Beijing & Chengdu.